Healthcare / Medical Care FacilitiesSaudi
$5.67
+0.31 (+5.68%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 27% · confianza 25%
FCF escenarios
weak_data · normalized FCF $9.4M · quality 54.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
40/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$437M
P/E
70.9x
↑EV/EBITDA
22.0x
↑ROE
10.9%
↑Gross Margin
29.3%
↓Debt/Equity
0.06
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+22.2%
FCF CAGR
-13.8%
FCF margin
7.1%
FCF / Net income
1.00x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $148.2M · net income $10.5M · FCF $10.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $148.2M | $148.2M | $110.8M | $100.3M | $81.2M |
| Net Income | $10.5M | $10.5M | $10.3M | $15.7M | $15.7M |
| EBITDA | $19.9M | $19.9M | $17.7M | $20.3M | $21.8M |
| EPS | — | — | 0.13 | 0.20 | 0.20 |
| Gross Margin | 29.3% | 29.3% | 25.7% | 31.4% | 30.7% |
| Operating Margin | 12.2% | 12.2% | 11.0% | 15.8% | 21.2% |
| Net Margin | 7.1% | 7.1% | 9.3% | 15.7% | 19.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.06 | 0.06 | 0.08 | 0.05 | 0.06 |
| Cash Flow | |||||
| Free Cash Flow | $10.5M | $10.5M | $-3.9M | $9.4M | $16.4M |
| Returns | |||||
| ROE | 10.9% | 10.9% | 10.9% | 17.1% | 18.0% |
| Valuation | |||||
| P/E | 70.88 | 70.88 | 54.31 | 30.40 | 23.70 |
| EV/EBITDA | 22.02 | 22.02 | 30.91 | 20.69 | 16.50 |
| P/B | 4.55 | 4.55 | 5.79 | 5.10 | 4.19 |
| Growth & Yield | |||||
| Revenue Growth | 33.8% | 33.8% | 10.4% | 23.5% | — |
| EPS Growth | — | — | -35.0% | 0.0% | — |
| Dividend Yield | 3.1% | 3.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-12.5%
Start / end P/E
n/dx → n/dx
EPS bridge
0.13 → n/d
Residual
-15.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.